Inhibikase Therapeutics, Inc. (IKT)
NASDAQ: IKT · Real-Time Price · USD
2.310
0.00 (0.00%)
At close: Sep 16, 2026, 4:00 PM EDT
2.320
+0.010 (0.43%)
After-hours: Sep 16, 2026, 7:30 PM EDT
Inhibikase Therapeutics Analyst Ratings
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Maxim Group | Maxim Group | Buy Maintains $8 | Buy | Maintains | $8 | +246.32% | Aug 14, 2026 |
| Oppenheimer | Oppenheimer | Buy Maintains $5 | Buy | Maintains | $5 | +116.45% | Aug 12, 2026 |
| LifeSci Capital | LifeSci Capital | Buy Maintains $5 | Buy | Maintains | $5 | +116.45% | Aug 11, 2026 |
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $8 | Buy | Reiterates | $8 | +246.32% | Jul 31, 2026 |
| Bank of America Securities | Bank of America Securities | Buy Maintains $6 | Buy | Maintains | $6 | +159.74% | Jul 28, 2026 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Maintains $4 | Buy | Maintains | $4 | +73.16% | May 19, 2026 |